Asymptomatic coronary heart disease in patients with type 2 diabetes with vascular complications: a cross-sectional

Tetsuro Tsujimoto1, Hiroshi Kajio, Yoshihiko Takahashi

  • 1Department of Diabetes and Metabolic Medicine and Diabetes Research Center, National Center for Global Health and Medicine, Tokyo, Japan.

BMJ Open
|October 25, 2011
PubMed

Insights

Many patients with type 2 diabetes and vascular complications have undiagnosed coronary heart disease (CHD). This study found over half had asymptomatic CHD, highlighting the need for screening in this high-risk group.

Area of Science:

  • Cardiology
  • Endocrinology
  • Vascular Medicine

Background:

  • Microvascular and macrovascular diseases are linked to coronary events.
  • Diabetes mellitus is a significant risk factor for cardiovascular complications.
  • Vascular complications in diabetes may indicate underlying coronary artery disease.

Purpose of the Study:

  • To determine the prevalence of asymptomatic coronary heart disease (CHD) in patients with type 2 diabetes and vascular complications.
  • To investigate the association between vascular complications and undiagnosed CHD.
  • To identify risk factors for asymptomatic CHD in this population.

Main Methods:

  • A cross-sectional study was conducted at a national diabetes center in Japan.
  • 122 patients with type 2 diabetes and vascular complications (retinopathy, nephropathy, peripheral arterial disease, or cerebrovascular disease) were enrolled.
  • Stress single-photon emission computed tomography (SPECT) and coronary angiography were used to assess for CHD.

Main Results:

  • 79% of patients exhibited myocardial perfusion abnormalities on SPECT.
  • 53% of patients had asymptomatic coronary heart disease with ≥50% diameter stenosis.
  • Male sex was the only significant predictor of asymptomatic CHD (OR 6.18).

Conclusions:

  • Asymptomatic coronary heart disease is highly prevalent in patients with type 2 diabetes and vascular complications.
  • Myocardial perfusion abnormalities and significant coronary stenosis were common findings.
  • Routine screening for CHD should be considered in diabetic patients with existing vascular disease.
Abstract

Related Concept Videos

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...